1. American Cancer Society. Cancer Statistics, 2012. Available at: http://onlinelibrary.wiley.com/doi/10.3322/caac.20138/full. Accessed: June 9, 2012. 2. National Cancer Institute.

Prostate Cancer Screening. Available at: http://www.cancer.gov/cancertopics/pdq/screening/prostate/HealthProfessional/page2. Accessed June 9, 2012. 3. Washington C, Leaver D. Principles and Practice of Radiation Therapy. 3rd ed. St. Louis, MO: Mosby/Elsevier; 2010. 4. Filella X, Alcover J, et al. Clinical evaluation of free PSA/total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer. Eu J Cancer. 1997;33(8):1226-1229. 5. Bostwick D, Eble J. Urological Surgical Pathology. 3rd ed. St. Louis, MO: Mosby/Elsevier; 2007. 6. Chao KSC, Perez CA, Brady LW. Radiation Oncology Management Decisions. 2nd ed. Philadelphia PA: Lippincott Williams & Wilkins; 2002. 7. Eng T, Herman T. Primary radiation therapy for localized prostate cancer. Urol Onc. 2002;20(2):239-257. 8. Badaus L, Bolla M, et al. Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of literature. Eu Urol. 2012;61(1):112-117. 9. Epstain B, Hanks G. Radiation therapy techniques and dose selection in the treatment of prostate cancer. Sem Rad Oncol. 1993;3(3):179-186. 10. el-Gabry E, Halpern E, Strup S, Gomella L. Imaging prostate cancer current and future applications. Oncol. 2001;15(3):325336. 11. Bentel G. Radiation Therapy Planning. 2nd ed. St. Louis, MO: McGraw-Hill; 1996. 12. Perez CA, Pilepich MV, Zivnuska F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1986;2(4):523-531. 13. Heemsbergen W, Peeters S, Koper P. et al. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage. Int J Radiat Oncol Biol Phys. 2006;66(1):3-10. 14. Iwamoto R, Maher K. Radiation therapy for prostate cancer. Sem Oncol Nur. 2001; 17(2):90-100. 15. Khan FM. The Physics of Radiation Therapy. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010.

16. Dearnaley D, Hall E. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer. 2005;92(3): 488-498. 17. Zelefsky M, Leibel S, Gaudin P, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41(3):491500.